Table 1.
Sample | Zeta‐potential mV | CC50Vero E6 [µg mL−1] | IC50FCoV [µg mL−1] | IC50SARS‐CoV‐2 [µg mL−1] |
---|---|---|---|---|
G‐PGS | −46 ± 5 | >1000 | >1000 | >1000 |
G‐PGS‐C6 | −46 ± 5 | >1000 | >1000 | >1000 |
G‐PGS‐C9 | −49 ± 7 | >1000 | 749.4 ± 107.8 | 339.7 ± 128.8 |
G‐PGS‐C10 | −56 ± 11 | 63.4 ± 35.8 | 9.8 ± 10.2 | 29.1 ± 12.2 |
G‐PGS‐C11 | −54 ± 8 | 68.9 ± 26.4 | 6.3 ± 1.2 | 0.8 ± 0.3 |
G‐PGS‐C12 | −56 ± 10 | 100.1 ± 40.2 | 85.2 ± 50.9 | 22.9 ± 7.4 |
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.